Capital Markets Advisory
Our team leverages deep industry relationships to prepare and guide companies on how to access capital markets
LifeSci Advisors works with clients to develop an impactful investor communications program that starts with investment thesis development and corporate positioning.
Our corporate communications team—unique in our Wall Street experience and credibility—works with our clients on developing an effective corporate presentation with an emphasis on highlighting key messages for investors.
We draft and revise news releases and earnings call scripts. Moreover, we advise the drafting of other corporate materials including IR websites, fact sheets, FAQ’s and shareholder letters.
LifeSci Advisors hosts Key Opinion Leader (KOL) Events on behalf of clients. Events include webcasted and in-person meetings with leading healthcare experts as well as investor-only group meetings and teleconference calls surrounding important medical conferences and catalyst events.
LifeSci’s KOL events intend to further cultivate relationships with leading healthcare investors. They are focused on relevant and timely topics in the life sciences industry, including new clinical data and important regulatory milestones.
KOL events can be client-specific and designed to lend valuable third-party validation to a company’s products or technology, and put them in the context of the wider healthcare landscape. They are proven to be excellent opportunities for clients to raise their visibility with investors and industry professionals.
A non deal roadshow is the most reliable means for a company to build a strong investor base. LifeSci Advisors markets its clients to the top life sciences-focused institutional investors across the U.S., Europe, and Israel. The investor outreach process commences with an individualized peer-comparable shareholder analysis followed by the creation of a target list of investors and a strategic marketing program incorporating the company’s expected corporate news flow and milestones.
In addition to deep relationships with the buy-side, LifeSci Advisors has strong connections with sell-side analysts, investment bankers, specialty salesman and capital markets professionals. The firm leverages these relationships on behalf of its clients to attract additional sell-side coverage, to encourage investor conference invites, and to expand investment banking relationships. Moreover, LifeSci Advisors has an extensive network of retail brokers across the U.S. interested in healthcare investment opportunities.
Asia Pacific is a global hub for life sciences and medical technology R&D, investment, and partnering. Within the region, companies and investors retain a robust appetite for innovative and cutting-edge healthcare technology.
LifeSci Advisors hosts Non-Deal Roadshows in multiple markets across Asia Pacific (China, Japan, Singapore, Taiwan, South Korea, etc.) focusing on investor and partner introductions for clients. Our team cultivates an extensive Asia Pacific network of institutional investors, venture capital funds with international investment capabilities, and local companies looking to globalize through licensing deals and joint ventures.